Neoleukin Therapeutics Inc (NASDAQ:NLTX)
| 0.6698 BATS BZX Real-Time Price As of 10:54am ET |  +0.0249 / +3.86%Today’s Change | 0.38 Today|||52-Week Range 2.32 | +31.59% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Operating Activities | Net Income / Starting Line | -21.9M | -37.0M | -50.2M | -31.6M | |
| Total Other Cash Flow | 2.1M | 2.1M | 4.5M | 5.4M | ||
| Funds From Operations | -19.7M | -34.9M | -45.6M | -26.1M | ||
| Funds From/For Other Operating Expenses | 546.0K | -4.7M | -917.0K | 5.4M | ||
| Net Cash Flow - Operating Activities | -20.3M | -30.2M | -44.7M | -31.6M | ||
| Investing | Increase In Investments | -60.7M | -106.4M | -6.0M | 0.00 | |
| Decrease In Investments | 13.2M | 59.1M | 70.5M | 56.0M | ||
| Capital Expenditures | -27.0K | -713.0K | -494.0K | -49.0K | ||
| Fixed Asset Disposal | 1.0K | 0.00 | -- | -- | ||
| Net Cash Flow Investing | -47.5M | -48.1M | 64.0M | 56.0M | ||
| Financing | Short Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Long Term Borrowings | 0.00 | -- | -- | 0.00 | -- | |
| Long Term Debt Reduction | 0.00 | -4.0K | -15.0K | -32.0K | ||
| Net Proceeds Stock Sale | 92.9M | 71.1M | 438.0K | 602.0K | ||
| Common Preferred Redeemed | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Common Dividends | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Cash Dividends Paid - Total | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Sources - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Other Uses - Financing | 0.00 | 0.00 | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | 92.9M | 71.1M | 423.0K | 570.0K | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -527.0K | -53.0K | 15.0K | -48.0K | |
| Net Change In Cash | 25.1M | -7.2M | 19.7M | 24.9M | ||
